MIMETICS OF HORMETIC AGENTS: STRESS-RESISTANCE TRIGGERS by Sonneborn, Joan Smith
Dose-Response: An International Journal
Volume 8 | Issue 1 Article 19
3-2010
MIMETICS OF HORMETIC AGENTS:
STRESS-RESISTANCE TRIGGERS
Joan Smith Sonneborn
University of Wyoming, Laramie, WY
Follow this and additional works at: https://scholarworks.umass.edu/dose_response
This Article is brought to you for free and open access by ScholarWorks@UMass Amherst. It has been accepted for inclusion in Dose-Response: An
International Journal by an authorized editor of ScholarWorks@UMass Amherst. For more information, please contact
scholarworks@library.umass.edu.
Recommended Citation
Sonneborn, Joan Smith (2010) "MIMETICS OF HORMETIC AGENTS: STRESS-RESISTANCE TRIGGERS," Dose-Response: An
International Journal: Vol. 8 : Iss. 1 , Article 19.
Available at: https://scholarworks.umass.edu/dose_response/vol8/iss1/19
97
MIMETICS OF HORMETIC AGENTS: STRESS-RESISTANCE TRIGGERS
Joan Smith Sonneborn, Professor Emeritus  Department of Zoology and
Physiology, Box 3166 1000 E. University Avenue, University of Wyoming, Laramie,
Wyoming, 82071
 Mimetics of hormetic agents offer a novel approach to adjust dose to minimize the risk
of toxic response, and maximize the benefit of induction of at least partial physiological
conditioning. Nature selected and preserved those organisms and triggers that promote
tolerance to stress. The induced tolerance can serve to resist that challenge and can repair
previous age, disease, and trauma damage as well to provide a more youthful response to
other stresses. The associated physiological conditioning may include youthful restoration
of DNA repair, resistance to oxidizing pollutants, protein structure and function repair,
improved immunity, tissue remodeling, adjustments in central and peripheral nervous sys-
tems, and altered metabolism. By elucidating common pathways activated by hormetic
agent’s mimetics, new strategies for intervention in aging, disease, and trauma emerge.
Intervention potential in cancer, diabetes, age-related diseases, infectious diseases, car-
diovascular diseases, and Alzheimer’s disease are possible. Some hormetic mimetics exist
in pathways in primitive organisms and are active or latent in humans. Peptides, oligonu-
cleotides, and hormones are among the mimetics that activate latent resistance to radia-
tion, physical endurance, strength, and immunity to physiological condition tolerance to
stress. Co-activators may be required for expression of the desired physiological condi-
tioning health and rejuvenation benefits.
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INTRODUCTION
Hormesis represents the biphasic dose-response patterns to toxic
challenges that has been championed by Calabrese and colleagues
(Calabrese and Baldwin 2000). Low doses of otherwise harmful agents
are beneficial at threshold low levels. The beneficial hormetic response
involves the adaptive stress response to the low dose toxic challenge as
multiple conserved protective enzymatic and signaling systems are acti-
vated by stress (Smith Sonneborn 1992a,b). These fundamental survival
pathways, when activated, confer plasticity to species longevity (Arking et
al. 2004; Sonneborn 2005). Key regulators in these hormetic environ-
mentally and chemically cued pathways are candidates as hormetic
mimetics. Activation of these latent protective responses not only over-
come the immediate challenge but may also repair previous damage and
reduced vulnerability in the organism (Smith Sonneborn 1979). Natural
detoxifying systems, activated by a wide range of physical and chemical
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hormetic agents with ROS (reactive oxygen species) activity, trigger man-
ganese superoxide dismutase (MnSOD) and catalase, to neutralize super-
oxide anion and hydrogen peroxide, and DNA damage repair (Carter
and Brunet 2007). In diverse species, transcription factors, like the fork-
head-box (FOXO) transcription factor family in development and stress
resistance, activate a broad suite of cellular genes, including those encod-
ing enzymes involved in DNA repair and oxygen detoxification (Morris
2005) and are pro-longevity genes in invertebrates. The identification
and use of molecular mimetics of stress to access ancient molecular path-
ways for survival represents a major strategy for resistance to stress, dis-
ease prevention and recovery, rejuvenation, and extended life quality.
The focus of the present study is on molecular mimetics known to
induce entire or partial pathways in the stress response to specific
hormetic agents. Candidate pharmaceutical agents that imitate the phys-
ical and environmental emergency signals to activate complete or partial
molecular cascades common to heat, radiation, diet restriction, cell
immunity, exercise and trauma have been identified (Smith Sonneborn
2008) and are reviewed here as drugs with potential for intervention in
aging, disease and trauma. Evidence is accumulating that some protective
inducible responses to stresses may require co-activators. Co-activators are
metabolic switches, which together regulate metabolic pathways through
their multiple interactions with nuclear receptors and other transcription
factors (Feige and Auwerx 2007; Narkar et al. 2008). Activation of stress
intervention may be effective prior, during and after the stress interval.
The associated physiological conditioning and rejuvenation benefits
include stimulated DNA repair, endogenous antioxidants, restoration of
protein structure and function, immunoregulation and tissue remodel-
ing, and central and peripheral neuronal systematic and metabolic
responses to ischemia, and energy endurance. The conditioning benefits
pose potential intervention in cancer, diabetes, infectious diseases, heart
and kidney failure, inflammatory diseases including atherosclerosis and
Alzheimer’s disease, osteoporosis, and ischemic trauma injury from heart
attack, stroke, and hemorrhage.
Candidate mimetics reviewed include ethanol, thiols and metals, iso-
prenoids, oltipraz, ferritins, oligonucleotides, conserved peptide
sequences, biguanides, the sirtuin Resveratrol, AMPK and PPAR agonists,
and Hibernation Induction Trigger (HIT)-like delta opioid receptor ago-
nists, as examples of pharmaceutical triggers to stimulate the hormetic
physiological conditioning. The conserved hormetic pathways that mod-
ulate heat-shock proteins, antioxidant systems, IGF-1 and homeostatic
energy balance, accessed by mimetics of heat, radiation, caloric restric-
tion, immunoregulators, exercise, and hibernation, are reviewed with
their potential use in anti-aging, disease and trauma.
J. Smith Sonneborn
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HORMETIC HEAT MIMETICS
Molecular chaperones, the heat shock proteins (HSPs) are major
defense responses that enable proper refolding of damaged protein
structure induced by heat, alcohol, heavy metals, age, disease, oxidative
and post ischemic stress. Proteins structural refolding with molecular
chaperones avoids inactivation of proteins or abnormal aggregates
(Morimoto 2006). A conserved DNA sequence in the promoter of all
inducible heat shock genes provides an address of member genes for
transcription factor activation of the coordinated cascade of targeted
novel responsive gene expression when the cellular “911” signal is given.
Restoration of protein function by the activated HSP chaperoned folding
of proteins occurs in response to multiple protein denaturing agents
from chemical, environmental, or age related stress. Protein rejuvenation
of old cells may occur whenever the stressor activates the cascade by
restoration of activity-required three dimensional protein structures. As is
typical of hormetic agents, high doses of the stressing agent can overload
the system and result in uncontrolled degradation of necessary regulato-
ry molecules.
Elevated temperature increases lifespan in human fibroblasts and ker-
atinocytes (Rattan and Ali 2007). Heat treatment results in increased
basal levels of various chaperones, reduced accumulation of damaged
proteins, stimulated proteasomal activities for the degradation of abnor-
mal proteins, improved cellular resistance to ethanol, hydrogen perox-
ide, and UV-B rays, enhanced levels of various antioxidant enzymes, and
increased phosphorylation-mediated activities of various stress kinases.
Thus, heat confers cross-resistance to other hormetic agents. The effect
of combination of heat and potential hormetic molecules, such as cur-
cumin on aging, longevity, and differentiation of human cells in culture
is under investigation (Rattan and Ali 2007). Stress response genes, par-
ticularly HSP70, are now the major candidates in the gene-longevity asso-
ciation studies (Singh et al. 2007). Enhanced survival and growth rate
maintenance in bacteria after heat or cold shock, at 37° or 40° heat, or
12°C cold that results in expression of small HSPs (Fiocco et al. 2007).
Small HSPs overproduction of these HSPs leads to an enhanced survival
in the presence of butanol and ethanol.
Ethanol
Constitutive and inducible HSP70s are involved in oxidative resist-
ance evoked by heat shock and ethanol (Su et al. 1998). In the brain,
moderate ethanol pretreatment causes an almost 3-fold increase in brain
levels of heat shock protein HSP 70, and can prevent beta-amyloid pep-
tide (Abeta)-induced neurotoxicity and apoptosis in organotypic hip-
pocampal-entorhinal slice cultures and suggest possible molecular
Hormetic mimetics for health
99
3
Sonneborn: Hormetic mimetics for health
Published by ScholarWorks@UMass Amherst, 2014
mechanisms underlying the protective effect of moderate drinking against
Alzheimer’s dementia (Belmadani et al. 2004). Pretreatment of gerbils
with ethanol ameliorates behavioral deficit, neuronal death, and protects
the brain against Ischemia/Reperfusion (I/R)-induced delayed neuronal
death, neuronal and dendritic degeneration, oxidative DNA damage, and
glial cell activation (Wang et al. 2007). Ethyl alcohol evokes cross-resistance
to hydrogen peroxide in rat myocytes (Su et al. 1998) and protection
against the proinflammatory effects of I/R on the mesenteric artery and
reactive oxygen species (Yamaguchi et al. 2002). The cardioprotective
advantage of moderate consumption of ethanol in popular beverages “the
so-called French Paradox” may result from ethanol induced favorable
changes in lipid metabolism, antioxidant effects, changes in homeostasis
and platelet aggregation, arterial vasodilatation mediated by NO release,
expression of cardioprotective proteins, insulin sensitization and lower lev-
els of inflammatory markers. The presence of resveratrol and quercetin in
beverages are also partly responsible for some of the cardioprotective
effects of alcoholic drinks (Providencia 2006).
Interestingly, in yeast, different doses of ethanol induce different
responses. Over 4%v/v ethanol doses optimally induce heat shock pro-
moters, while 6-8%, induce the same two major changes in integral plas-
ma-membrane protein composition as sublethal heat stress. These
changes include reduction in levels of the plasma membrane ATPase pro-
tein, and acquisition of the plasma membrane heat-shock protein Hsp30
(Piper et al. 1994). In humans, a beneficial induction of plasma antioxi-
dants is achieved with one drink (5% v/v alcohol) while an increased pro-
oxidant state occurs after three drinks from volunteers averaged over 360
minutes. One drink of red wine, beer, or stout provided equivalent
increases in plasma antioxidant activity without induction of pro-oxida-
tive stress (Prickett et al. 2004). Thus, at different doses, different physio-
logical responses occur from benefit to harmful response.
Geranylgeranylactone (GGA)
GGA occurs naturally in herbs, may act as a defense mechanism in
plants, is synthesized in bone in vitro and in vivo, is inducible by UVC,
and participates in induction of apoptosis in a human hepatoma-derived
cell line (Shidoji and Ogawa 2004, Wang et al. 2002). As a heat mimetic,
this acyclic isoprenoid, is non toxic and safely induces HSP70 in cultured
guinea pig gastric mucosal cells and rat gastric mucosa. Pretreatment of
rats with GGA protects the liver, small intestine, or heart, and improves
survival after 95% hepatectomy from ischemia-reperfusion injury or liver
transplantation (Kawai et al. 2000). GGA apoptosis inhibition in normal
cells correlates with inhibited activation of c-Jun N-terminal kinases,
decline of mitochondrial membrane potential, and formation of apopto-
some by binding with Apaf-1. GGA induces other protective pathways like
J. Smith Sonneborn
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thioredoxin and anti-viral genes that offer a generalized upregulation of
disease immunity (Hirakawa et al. 1996). GGA also alleviates the patho-
logical progression of atrophic gastritis with inflammation relief (Liu et al.
2007), promotes bone osteoblasts, and is a potential anti-osteoporosis
agent (Wang et al. 2002).
Although low concentrations (1-100nM) of GGA reduce neurotoxici-
ty in cultured spinal cord, higher concentrations produce neurotoxicity
in spinal cord neurons (Kikuchi et al. 2002). This highly conserved mole-
cule in plants and animals has multiple beneficial effects in humans,
induces heat shock proteins, and intervenes in chronic and infective dis-
eases at low doses. It may have protective potential for use in pandemic
threats.
HORMETIC RADIATION MIMETICS
Mimetics of the beneficial effects of low dose radiation elicit resist-
ance pathways of repair without the potential of radiation damage.
Radiation tolerance, like heat tolerance, activate gene expression cas-
cades that promote survival and longevity from bacteria to man
(Gilchrest and Eller 2001). The DNA repair response is an ancient con-
served fundamental survival and longevity induced gene expression cas-
cade in cells and vertebrates (Hart and Setlow 1975; Gilchrest and Eller,
2001; Pollycove and Feinendegen 2001). In the single-celled protozoa,
Paramecium, exposure to ultraviolet radiation and photoreactivation
repair, accesses a 296% increase in remaining life span and reserve repair
pathways (Smith Sonneborn 1979).
Oligonucleotides
Mammalian cells are more resistant to higher radiation doses, show
enhanced repair, and correction of age related decline of repair in
human cells when stimulated by DNA oligonucleotides without radiation
(Gilchrest and Eller 2001; Goukassian et al. 2002). Thymidine dinu-
cleotides (pTpT), imitating a damage product of UV, stimulate melano-
genesis (tanning) in mammalian pigment cells and intact skin and
increase DNA repair rate. The pTT effects occur in the absence of initial
damage (Arad et al. 2007). UV oligonucleotide mimetics are capable of
reducing mutagenesis and carcinogenesis even by topical application
(Goukassian et al. 2004). Oligonucleotides, substantially homologous to
the telomere 3-prime overhang sequence (T-oligos), increase DNA repair
capacity in cultured human cells, decrease UV-induced mutation rate,
and reduce photocarcinogenesis in mouse skin as well (Arad et al. 2006).
The response efficacy depends at least crudely on their length and per-
cent telomere homology. Using a homologous 9 base oligo, 40 µM was a
maximally effective dose for induction of the protective p53 protein and
DNA repair, roughly bioequivalent to damage by UV (Arad et al 2006).
Hormetic mimetics for health
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The oligonucleotides used imitate damage products produced by UV
and senescence, and “trick” the cells into triggering a cascade of protective
molecular responses, like the 911 call, to deal with medical emergency.
In contrast with the beneficial effects of t-oligos on normal cells, t-oli-
gos induce death in cancer cells in a dose and time dependent manner
(Aoki et al. 2007). T-oligos inhibit the proliferation of malignant glioma
cells through induction of nonapoptotic cell death and mitochondria
hyperpolarization, whereas normal astrocytes are resistant. The t-oligos
trigger expression of a subset of genes for repair or apoptosis and type II
programmed cell death with potential for cancer treatment (Aoki et al.
2007).
Since cancer cells are more sensitive to oligo cytotoxicity than normal
cells (Aoki et al. 1007), oligo therapy may be a desired alternative or addi-
tion to radiotherapy, especially with the known differences in radiation
sensitivity of normal cells among patients.
Thiols, Zinc, Selenium
Another strategy for protection against radiation damage, is the
increase antioxidants levels at the endogenous and exogenous level,
when ROS inducing agents activate an antioxidant subset of gene expres-
sion (Beani 2001; Hamilton 2007). Instead of increased repair of UV
damage, antioxidants reduce the damage and therefore the need for
repair. Antioxidant mimetics of low dose UV response, that target the
cytotoxic ROS effects of UVA and UVB and reduce DNA damage, include
thiols, zinc and selenium. ROS protection involves an increase in glu-
tathione peroxidase activity. Their results show that thiols and selenium
protect cells against UVA radiation with a synergic interaction. This pro-
tection acts though an increase in glutathion peroxidase activity. Zinc
protects against cytotoxicity of UVA and UVB and against UVB induced
DNA damages.Antioxidant thiols, including N-acetyl cysteine, glu-
tathione, and thioproline, at doses 100-300 micro M, reduce gamma radi-
ation damage to human lymphocytes DNA, and closely correlate with the
reduction of cellular oxidative stress via multiple mechanisms (Tiwari et
al. 2009). The higher the damage, the higher the dose of these antioxi-
dants needed for benefit.
As DNA damages play a role in photocarcinogenesis, activation of
antioxidant expression provides protection against UV or gamma
induced oxidative damage. Cross-resistance is an under used strategy in
biology and medicine in carcinogenesis, aging, and preservation of cell
and tissue function. Since exercise can elevate antioxidant pathways
(Hamilton 2007), exercise should provide cross-protection against radia-
tion damage.
J. Smith Sonneborn
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Antioxidant Response Element Activators-Oltipraz, and Ferritin agonists
Protection against carcinogenesis, mutagenesis, and other forms of
toxicity mediated by carcinogens, is the induction of enzymes involved in
their metabolism. Potent chemopreventive agents include the 1,2-dithi-
ole-3-thiones (Kwak et al 2001). Oltipraz, a substituted 1,2-dithiole-3-
thione, originally developed as an anti-schistosomal agent, possesses
chemopreventive activity by transcriptional activation of a gene cascades
involved in carcinogen detoxification and attenuation of oxidative stress
(Kwak et al. 2001). Exposure of rodents to 1,2-dithiole-3-thiones trigger
nuclear accumulation of the transcription factor Nrf2 and its enhanced
binding to the “antioxidant response element” (ARE), that lead to tran-
scriptional activation of a multiple genes involved in carcinogen detoxifi-
cation, and attenuation of oxidative stress. The dose required for effec-
tiveness depends on environmental challenges and severity.
Ferritins, an ancient family of protein nanocages, also participate in
activation of the ARE responsive element. Ferritans concentrate iron in
iron–oxy minerals for iron–protein biosynthesis and protection against
oxy radical damage. The promoter of human ferritin-L, contains an over-
lapping Maf recognition element (MARE) antioxidant responsive ele-
ment (ARE). The ferritin receptor is activated by tert-butylhydroquinone,
sulforaphane, and hemin with responses comparable to thioredoxin
reductase (ARE regulator) or quinone reductase (MARE/ARE regula-
tor). The combination DNA and mRNA mechanisms of regulation, like
those used for ferritin-L, illustrates the advantages of using two types of
genetic targets to achieve sensitive responses to multiple signals (Hintze
and Thiel 2005). This class of radiation mimetics represent triggers of
protective responsive cascades by binding to a receptor element that acti-
vate antioxidant transcription that neutralize ROS damage produced by
multiple physical and chemical hormetic agents. High doses of the
antioxidant, butylhydroquionone, are neurotoxic (O’Donoghue 1985).
DIET RESTRICTION MIMETICS
Caloric Restriction (CR) is not simply a passive effect, but an active,
highly conserved response to stress involving both central and peripher-
al effects of the ancient conserved signaling pathway, Insulin/IGF-1,
important in aging, longevity, and cancer and as a hormetic agent
(Sinclair 2005, Hayes 2008). Diet restriction as a hormetic agent is
reviewed recently (Hayes 2008). The potential of antiglycation agents and
cross-link breakers holds promise for correction of age related maladies
delayed by CR and are recently reviewed (Smith Sonneborn 2008).
Pharmaceutical mimetics could produce the beneficial health-promot-
ing, anti-aging and anticancer effects of caloric restriction (McCarty 2004;
Anisimov et al. 2005). Mimetics, even if only of partial benefit, range from
Hormetic mimetics for health
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glycolytic inhibitors, lipid regulating agents, antioxidants, sirtuin regula-
tors, autophagic enhancers, insulin specific gene modulators, weight loss
drugs(Roth 2005; Lane et al. 2007; Anisimov 2006), and cell energy regu-
lators(Hardie 2007). Candidate CR mimetics used in treatment of dia-
betics have been effective in eliciting positive metabolic changes among
the biguanides; the diabetic drug, phenformin and metformin stimulate
activation of AMP-activated kinase (AMPK) that down regulates insulin
secretion, suppresses IGF-1, and lowers blood glucose even in non-dia-
betics and embryos in high glucose(Zhou et al. 2001; Eng et al. 2007).
However, high doses of some biguanides do induce especially lactic aci-
dosis and renal toxicity (Chang et al. 2002).
Exercise can be a dramatic hormetic conditioner that can promote
weight loss and provide the associated weight loss CR benefits. Changes
in body weight (or CR) alter the response of an organism to chemical and
physical agents, and can improve their ability to withstand chemical and
physical challenges (Turturro et al. 2000). i.e., an altered hormetic
threshold response.
AMPK agonist, AICAR, and PPARδ agonist, GW1516, are mimetics
that alter cell energy regulation and are mimetics of CR and/or exercise
described below. Resveratrol, a member of sirtuin family, shows promise
as a CR mimetic as well, though the mechanisms of action are still under
investigation.
AICAR-AMPK Agonist
The strategy to alter cell energy drugs as CR or exercise mimetics, tar-
gets AMP-kinase, an evolutionary conserved regulator of cell energy that
interacts with the Insulin IGF-1 pathway (Zhou et al. 2001; McCarty 2004;
Hardie 2007, Hardie and Carling 1997, Narkar et al. 2008). AICAR (5-
aminoimidazole-4-carboxamide ribonucleoside) activates AMPK (Corton
et al. 1995) and serves as an energy regulating mimetic of AMPK. AICAR
is phosphorylated to form the AMP analog ZMP, creating an only “appar-
ent” high AMP which “tricks” the activation of AMPK. The kinase is acti-
vated by high AMP and low ATP via a complex mechanism, which involves
allosteric regulation, promotion of phosphorylation by an upstream pro-
tein kinase (AMPK kinase), and inhibition of dephosphorylation. This
protein-kinase cascade represents a sensitive system, which is responsive to
cellular stresses that deplete ATP, and thus acts like a cellular fuel gauge
(Hardie and Carling 1997). AICAR may be beneficial for energy mainte-
nance altered by unrelated illnesses, chemical toxins, trauma, and aging.
Activated protein kinase (AMPK), by metformin or mimetic AICAR,
protects cells against environmental stress and hypoxia (Mu et al. 2001),
and has antioxidant suppression of ROS (Kim et al. 2008). Activation of
the kinase may be a key regulator of energy-related hormetic responses
and AICAR may alter the toxicity of some energy disrupting hormetic
J. Smith Sonneborn
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agents. AMP-activated protein kinase contributes to UV- and H2O2-
induced apoptosis in human skin keratinocytes (Cao et al 2008).The
AMPK cross talk with the ancient FOXO pathway favors increased
longevity seen with caloric restriction (Greer et al. 2007). In diverse
species, transcription factors, belonging to the forkhead/winged helix
box gene, FOXO subfamily, used in fly eye development, are crucial in
downstream suppression of the life-shortening effects of insulin/insulin-
like growth factor-I receptor. The FOXO pathway suppresses increased
generation of ROS and promotes increased longevity in nematodes
(Greer et al. 2007). Several age-related diseases, including hypertension,
atherosclerosis, type 2 diabetes, cancer, and Alzheimer’s disease, could be
counteracted by the AMPK-FOXO activated pathways (Morris 2005).
AICAR inhibits cancer cell proliferation via the AMP-activated pathway
(Ratten et al. 2005). AICAR treatment increases oxygen consumption and
endurance in untrained adult mice in part by stimulating PPARδ-dependent
oxidative genes (Narkar et al. 2008). AICAR mimics the antioxidant
upregulation, decreased apoptosis, anticancer and anti-toxicity response
as well as an altered glucose uptake seen with caloric restriction. AMPK is
a key regulator of stress response, and when activated by AICAR, promis-
es multipurpose application potential. Other applications include reduc-
tion of intracellular pH by AMPK inhibition pH (Ségalen et al. 2008),
anti-inflammatory/anti-oxidant and neuroprotective functions possibly
useful in treatment of Alzheimer’s disease (Ayasolla et al. 2005), and
potentiating chemotherapy cytotoxicity by promoting influx of an anti-
folate drug used to eliminate leukemic cells (McGuire et al. 2006).
In human toxicity studies, 10-100mg/kg AICAR dosages were non-
toxic (Dixon et al. 1991). In rat cell cultures, non toxic doses and time
dependent increase of P-AMPK correlates with increase in AICAR doses,
indicating activation of the enzyme (Galardo et al. 2007). Only beneficial
dose ranges are available in these studies.
GW1516-PPARδ (Peroxisome Proliferators Receptors) Agonist
The evolutionary conserved, PPARs are ligand-activated nuclear tran-
scription factors that play important roles in lipid and glucose homeosta-
sis. The PPARδ receptor plays a key role in the reversal of any tendency
toward the development of insulin resistance by modulation of whole-
body lipid homeostasis as well as in insulin sensitivity. PPARδ activates a
transcriptional program in skeletal muscle leading to a switch in fuel
usage from glucose/fatty acids to solely fatty acids, thereby drastically
increasing its oxidative capacity and verified in humans. The inducible
control of fuel use by PPARδ is pivotal in metabolic adaptation of skeletal
muscle to a greatly increased oxidative capacity by switching from glu-
cose/fatty acids to solely fatty acids during energy stresses of fasting or
physical challenges and therefore as a caloric restriction hormetic agent
Hormetic mimetics for health
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(de Lange et al. 2008). The PPARδ agonist GW1516 (2-[2-methyl-4-([4-methyl-
2-[4-(trifluoromethyl)phenyl)-1,3-thiazol-5-yl]methylsulfanyl]phenoxy]acetic
acid) induces activation of PPARδ and reduces glucose utilization in
skeletal muscle through a switch in mitochondrial substrate preference
from carbohydrate to lipid (Brunmair et al. 2006). The GW1516 regulates
glucose metabolism and insulin sensitivity, as a partial mimic of caloric
restriction (Lee et al. 2006).
The toxicity of different ligands, like GW1516 for PPAR activation,
reveal organ specific benefit or toxicity; ie., potentiating hepatic toxicity
is possible (Peraza et al. 2006). As a benefit, in the liver, the liver X recep-
tors (LXRs) are established mediators of lipid-inducible gene expression
and also participate in inflammation and immunity. In vivo, LXR ago-
nists, including GW1516, reduce inflammation in a model of contact der-
matitis and inhibit inflammatory gene expression in the aortas of athero-
sclerotic mice, linking lipid metabolism and inflammation (Joseph et al.
2003). The use of PPAR ligands as mimetics for diet restriction hold
promise for reduction of age related diseases, but require caution. The
roles of PPARδ and GW1516 in exercise are described below.
Resveratrol
Resveratrol, a plant derived polyphenol, sirtuin activator, and phyto -
estrogen (Gehm et al. 1997) is another candidate mimetic of diet restric-
tion, though the exact mechanisms of the beneficial activation are
unknown. As a phytoestrogen, resveratrol can inhibit the binding of
labeled estradiol to the estrogen receptor and activate transcription of
estrogen-responsive reporter genes transfected into human breast cancer
cells, and that may not be appropriate in combination with other drugs.
These ancient NAD+ dependent sirtuins (Silent Information
Regulators), are a class of proteins which possess either histone deacetylase
or mono-ribosyltransferase activity and are found in organisms ranging
from bacteria to humans (Zhao et al. 2004; North and Verdin 2004). These
deacetylases increase organ, tissue and organism survival, especially under
conditions of stresses of nutrient deprivation, and physical and chemical
toxicity (Yang and Sauve 2006). Pharmacological approaches that target sir-
tuins offer attractive drugs to enhance toxicity resistance, especially the
FOXO regulatory gene expression cascades and survival benefits of caloric
restriction (Guarente and Picard 2005). Resveratrol has antioxidant pro-
tection against UV- and H2O2-induced cell death (van der Horst et al. 2004).
In mammals, SIRT1 utilizes FOXO and other pathways to achieve their
beneficial effects on health lifespan (Morris 2005). In humans the Sir2p
homolog, SIRT1, deacetylates transcription factors and mediates stress
resistance, apoptosis, and inflammatory responses in response to toxicity
using FOXO (Brunet et al. 2004; Kobayashi et al. 2005), p53 (Luo et al. 2001;
Langley et al. 2002) and NF-KappaB-dependent transcription (Yeung et al.
J. Smith Sonneborn
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2004; Chen et al. 2005). Activation of these pathways connects Sir2, caloric
restriction, and radiation hormetic cascades that have cross-reactive bene-
fits from their specific known mimetics.
The concentration and cell type can influence the dose responses to
resveratrol and influence pro-oxidant properties that lead to oxidative
breakage of cellular DNA in the presence of transition metal ions such as
copper. The pro-oxidant properties provide a potential anticancer thera-
py (de la Lastra and Villegas 2007).
EXERCISE MIMETICS
Interaction between the quality of the environment and the health of
the exposed population, determines the survival response of living organ-
isms. The phenomenon of induced tolerance, by exposure to hormetic
agents at threshold levels, stimulates natural defense mechanisms that
have potential therapeutic value (Smith Sonneborn 1992 a,b). Exercise,
heat and oxidative stress are hormetic agents (Sonneborn and Barbee
1998; Radak et al. 2008). The induction of heat shock proteins and the
ubiquitin pathways are key regulators of stress response are seen from
yeast to humans. Ubiquitin and heat shock pathways are involved with
peroxisome biogenesis, AMPK pathways, cell cycle control, DNA repair,
differentiation, sporulation, and in response to hormetic agents (Finley
et al. 1987; Fornace et al. 1989; Ryan et al. 1991;Salo et al. 1991; Thompson
and Scordilis 1994, Ciechanover 1994;Skidmore et al. 1995;Locke et al.
1996; Locke 1997; Sonneborn and Barbee 1998). Using moderate exer-
cise as the stressor, human blood shows a significant increase in abun-
dance of inducible polyubiquitin genes. The molecular cascades of gene
expression induced by exercise are multiple and document exercise as a
hormetic agent with therapeutic potential for benefit and energy upreg-
ulation. The mimetics of exercise show how a drug, AICAR, can imitate
the energy benefit. Cross talk between major caloric restriction hormesis
induced pathways especially AMPK/PPARδ and IGF1 reveal the linking of
caloric restriction and exercise mimetics (Narkar et al. 2008).
AICAR AMPK Agonist
The use of mimetic drugs to replace the “hormetic exercise physical
agent” has obvious health benefits for voluntary and involuntary seden-
tary populations and athletic performance. Investigation of pathway-spe-
cific drug mimetics of key regulators of cell energy reveals that the oral-
ly active AMPK agonist AICAR, improved endurance capacities using
mice treadmill running test even in sedentary animals (Narkar et al.
2008). Remarkably, this oral active AMPK kinase agonist mimetic, over-
comes the exercise requirement. Only 4 weeks of AICAR treatment
alone induces metabolic genes and enhances running endurance by
44%. ACIAR-only treated mice ran longer (123%) and further (144%)
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than did vehicle-treated mice, revealing mimetic induced endurance
without exercise. The other candidate exercise mimetic, the PPARδ ago-
nist, GW1516, alone, could not increase running endurance despite the
fact that transgenic mice with overexpression of activated PPARδ, main-
tain high basal endurance capacity to adult and exhibit 100% increase in
endurance in untrained mice (Wang et al. 2004). In these transgenic
mice, overexpression of a constitutively active PPARδ (VP16-PPARV δ) in
skeletal muscles preprograms an increase in oxidative muscle fibers,
enhancing running endurance by nearly 100% in untrained adult mice.
Only the combination of Exercise training with GW1516, could increase
running time by 68% and distance by 70% over vehicle-treated trained
mice (Narkar et al. 2008). Thus, increased running endurance and
myofibers induced by GW1516 require synergistic co-activation of
Exercise and the GW1516, though AICAR alone is a sufficient inducer of
energy endurance. Their studies reveal that gene expression signatures
of AICAR only versus Exercise plus GW1516 share about 40% of gene
expressions that function in oxidative metabolism, angiogenesis, and
glucose sparing, pathways in muscle performance modification.
Simultaneous AICAR AND GW1516 treatment creates a unique gene
expression signature that shares 40% of the genes in common with
Exercise plus GW1516, mostly oxidative metabolism genes that repro-
gram skeletal muscle. AICAR Only, induces a subset 32 genes, linked to
oxidative metabolism, also upregulated in transgenic mice overexpress-
ing PPARδ. Their supposition, that stimulation of oxidative genes by
AMPK, depends on the PPARδ receptor, is consistent with the observa-
tion that AICAR is ineffective in PPARδ null mutant cells. Thus, AICAR
induced transcription of oxidative genes requires an active PPARδ recep-
tor. Transgenic over-expression as well as knockout studies have identi-
fied PPARδ and AMPK as key co-regulators of type I fiber specification,
mitochondrial biogenesis, endurance adaptations and performance
enhancement during exercise. A “muscle endurance gene signature”
involves molecular crosstalk and perhaps a physical association between
exercise-activated AMPK and PPARδ receptors (Narkar et al. 2008).
Their study provides a novel pharmacologic strategy to reprogram mus-
cle endurance by targeting AMPK-PPARδ signaling axis with orally active
drugs and elegantly correlates molecular expression with physical
response. The mimetics induce gene expression both common as well as
unique with the hormetic agent exercise. The increased endurance
effect requires the key regulator of cell energy, the AMPK kinase agonist.
The PPARδ receptor agonist, GW1516, operated only in synergy with
exercise pathways. As a model study of hormetic mimetics, the exercise
experimental results reveal that a mimetic targeting AMPK can imitate
the “hormetic agent gene expression signature” sufficiently to gain a bio-
medical advantage of exercise; endurance and energy. Co-activations
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were required to achieve the geroprotective or athletic advantages using
the PPARδ mimetic alone. Interestingly, the mimetics induce their own
unique gene expression patterns, not found in the original hormetic
agent exercise, and long term effects of these “extra gene expression sig-
natures” are unknown with respect to benefit or harm.
In a different arena, the toxicity of pollutants, known to interfere with
PPAR nuclear receptors, like phthalates and organotins (Casals-Casas et
al. 2008), may be diminished by regulators of metabolic homeostasis,
AICAR and/or GW1516 or HIT mimetics.
In the classic exercise experiments by Narkar et al. 2008, the concentra-
tion of mimetics used was only 5mg/kg, sufficient to induce replacement of
exercise requirement and/or increase endurance. Whether higher concen-
trations of these mimetics, in these protocols, would increase or decrease
the benefits are unknown. Dose dependent effects of AICAR or GW1516 in
other biological arenas appear in the Diet restriction section above.
IMMUNOREGULATION
The immune response, though essential for survival, can participate in
autoimmune diseases. Thus, like hormetic agents, can be beneficial or harm-
ful. The beneficial elements include highly conserved peptides and oligos.
CDR1 Peptide and CpG Oligos
A preserved ancient immune response T cell immunoregulator of
sharks is effective in higher organisms ((Marchalonis et al. 1998;
Marchalonis et al. 2005). Sharks possess the genes essential for mounting
the adaptive or combinatorial immune response involved in homeosta-
sis, immunoregulation and response to infection. All three shark species
possess constitutive antibodies to shared idiotypes defined by the CDR1
segment of the T cell receptor beta chain variable domain (Adelman et
al. 2004). Certain TCR Vb CDR1 peptides can reverse the negative
effects of immunosenescence on normal TH1 and TH2 T cell subsets
and restore resistance to cardiopatholgy in mice. The TCR peptide itself
restores balance between TH1 and TH2 and stimulated cells remodeling
defective heart tissue implicating a role for immune system in cardiac
repair (Yu et al. 2005). Net collagen synthesis increases by downregula-
tion of matrix metalloproteinase and altered fibroblast expression and
enzymatic activity. The natural immunomodulatory system enhance-
ment, by administration of peptides (CDR1) to reduce cytokine dys-
function in immunosuppressed individuals and upregulate inflammato-
ry activities mediated by TH2-type helper cells, is likely. There is an adap-
tive role of T cells from peptide treated mice in remodeling damaged
hearts by increasing net collagen synthesis by cardiac fibroblasts as post-
exposure physiological conditioners and restoration of declined immu-
nity typical of aging populations.
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Synthetic CDRs, from unrelated murine and human monoclonal Abs,
show differential in vitro and in vivo antifungal (Candida albicans), antivi-
ral (HIV-1) and antitumor (melanoma cells) activities (Magliani et al.
2009). Candidacidal activity can be optimized by alanine replacement of
a single residue containing the first three amino acids of CDR1, to show
dose dependence with a 50% inhibitory concentration of 0.056 µM
(Polenelli et al. 2003).
Multiple roles to repair or provide anti-infective protection emerge
from use of peptides conserved from primitive immune systems. The
effective dose required depends on the desired benefit and optimized
peptide sequence. Unmethylated CpG motifs are prevalent in bacterial
but not vertebrate genomic DNAs.
Oligodeoxynucleotides containing CpG motifs activate host defense
mechanisms leading to innate and acquired immune responses. The
recognition of CpG motifs requires the Toll-like receptor. CpG-induced
activation of innate immunity protects against lethal challenge with a
wide variety of pathogens, and has therapeutic activity in murine models
of cancer and allergy. CpG motifs also enhance the development of
acquired immune responses for prophylactic and therapeutic vaccination
(Krieg 2002).
When used as an adjuvant, the dose of CPG 7909 for the highest anti-
body response depends on the saturation concentration to the
Alhydrogel (Mullen et al. 2007). Thus, defense peptides and oligonu-
cleotides, used in lower organisms, are of benefit to humans for a variety
of infectious and disease states. The dose response is dependent on the
synthetic form, and desired strategy for the intended therapeutic target,
i.e., direct or adjuvant therapy.
HIBERNATION
Hibernation is a biological strategy used to tolerate stress of depleted
energy stores, intracellular acidosis, hypoxia, hypothermia, cell volume
shifts, and inactivity induced muscle wasting (Harlow et al. 2001).
Multiple stresses share the same toxic physiological responses ameliorat-
ed by hibernation. Hibernation therefore, or the trigger that activates its
protective mechanisms, may be an intervention for multiple stresses
including environmental toxins, disease states, trauma, and aging.
Hibernation Induction Trigger (HIT) is an 88 residue opioid-like peptide
from hibernating woodchucks (Horton et al. 1998). HIT protects skeletal
muscles from hypoxia/reperfusion injury, and preservation of graft tissue
(Hong et al. 2005), cardiac ischemia (Sigg et al. 2002; Smith Sonneborn et
al. 2004;) and neuroprotection in a physiological preconditioning
hormesis pattern (Govindaswami et al. 2008). The delta 2 opioid recep-
tors, DADLE, and Deltorphins are mimetics of HIT.
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DADLE
HIT mimetics are delta opioid peptide receptor agonists that show
ischemia resistance potential in both physiological conditioning and
postexposure conditioning hormesis. DADLE. [D-Ala(2)-D-Leu(5)-
Enkephalin] DADLE is protective against neurotoxins, ameliorates the
neuronal damage induced by ischemia-reperfusion following a transient
middle cerebral artery occlusion, induces hibernation in hela cells, and
activates the beneficial recompensatory phase (Hayashi et al. 2002;
Borlongan et al. 2004; Vecchio et al. 2006).
Deltorphins
Deltorphins are found in epidermal secretions of Phyllomedusa bicolor,
a South American frog, that is used topically by Peruvian tribes to
increase physical strength, heighten senses, resist hunger and thirst and
promote fearless emotion before a hunt (Erspamer et al. 1993). The delta
2 specific variant (Tyr-d-Ala-Phe-Ala-Asp-Val-Ala-Ser-Thr-Ile-Gly-Asp-Phe-
Phe-His-Ser-Ile-NH2), (Delt D), mimicks the HIT-Winter containing
blood serum by cardioprotection from pretreatment of surgically
induced left coronary artery occlusion, that restricted blood flow to the
heart (Sigg et al. 2002; Smith Sonneborn et al. 2004;) and is neuroprotec-
tive during ischemia (Govindaswami et al. 2008). The physiological con-
ditioning hormesis cardioprotection in rodents is associated with activa-
tion of KATP channels (Sigg et al. 2002; Smith Sonneborn et al. 2004).
Delt D var but not DADLE, inhibits LPS proinflammatory cytokine pro-
duction by macrophages and suppress LPS-induced p38 MAPK activation
and expression of TNFalpha and MIP-2 (Husted et al. 2005). Thus, del-
torphin has anti-inflammatory activity.
Postexposure physiological conditioning hormesis with Delt D var
facilitates recovery from moderate (~30%) hemorrhage after blood pres-
sure crash in conscience rats (McBride et al. 2005) by activation of Mean
Arterial Pressure (MAP) and Heart Rate (HR) recovery through disinhi-
bition of sympathetic drive and increased baroreflex sensitivity. By reset-
ting baroreflex sensitivity animals are able to respond to decreases in arte-
rial pressure by increasing heart rate after moderate hemorrhage
(McBride et al. 2005). Delt D var also stimulates effective physiological
conditioning hormesis. Treatment 24 hr prior to hemorrhage facilitates
recovery from severe (~53%total blood loss) hemorrhagic shock during
the recompensatory phase by improving hemodynamic stability and sur-
vival with activation of both nitric oxide and KATP channels during hem-
orrhage (Oeltgen et al. 2006). Delt-Dvar-induced tolerance to cardiac
ischemia involves protein kinase C, NO synthase, KATP channels, and the
autonomic nervous system (Maslov et al. 2009). MAP recovery correlates
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with retardation of the anaerobic glycolytic pathways inducing metabolic
depression similar to that seen in hibernation.
Delt E, (Tyr-D-Ala-Phe-Ala-Ile-Gly-Asp-Phe-Ser-Ile-NH2) another novel
peptide mimic of HIT is δ2 opioid receptor agonist effective in postex-
posure conditioning hormesis. Within a stimulatory dose range,
Deltorphin E restores hemodynamic stability after severe hemorrhage
(~50%) treatment using behaving rodents (Rutten et al. 2008). Our
recent studies show that this peptide was effective in maintenance of
Mean Arterial pressure without fluid replacement and increased post
hemorrhage survival time. The dose dependent reduction of lactic acid
acidosis in the stimulatory range after hemorrhage predicted survival
time. Comparison of Delt-E mediated survival time versus lactic acid post
hemorrhage shows a significant (R2 = 0.969) dose response correlation
between the decrease in lactic acid and increase in survival time. For
every 0.1 mmol/L decrease in lactic acid there is a 12.5 minute increase
in survival time (2.9 mg/kg, 4.3mg/kg and to 5.5mg/kg Delt E. However,
14mg/kg Delt E exacerbated the stress and was lethal. Thus, Delta E opi-
oid is beneficial within a low dose range and toxic at the high dose test-
ed. Our results show that protection from ischemic shock, without fluid
replacement is dose dependent, effective in a lower dose range, while
toxic at the higher dose used (Rutten et al. 2008).
Altered energy metabolism by Delt E may be a candidate alone or in
combination with anti-diabetic drugs to provide stable metabolic states
and to reduce posttraumatic syndromes. Since heat stress alters the meta-
bolic state, DeltE may be an intervention strategy.
Thus, mimetics of HIT, DADLE, DeltD and DeltE can elicit physio-
logical conditioning or postexposure physiological conditioning horme-
sis. The mechanisms of the conditioning responses, though not yet fully
characterized, depend on the extent of severity and the specific mimetic.
These opioids provide a potent potential for use in emergency trauma
setting i.e. in wartime, natural disasters, accidents, or in anticipated criti-
cal surgical procedures with risks of ischemic stress and in combination
with other hormetic agents.
CONCLUSIONS
Conserved pathways in diverse species identify latent reservoirs of
guardian mechanisms that when activated can improve intervention in
human diseases, survival, rejuvenation, and longevity (Table 1, 2).
Remarkable progress in the recent decades reveal the powerful potential,
and proven success of mimetics of physical and chemical hormetic agents
to trigger these pathways. Mimetic drugs of hormetic agents activate gene
expression signatures that imitate heat, radiation, diet restriction, exer-
cise, immune response and hibernation for treatment and/or prevention
of diseases including diabetes, Alzheimer’s disease, cancer, inflammatory
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TABLE 1: Conserved survival and longevity hormetic inducible pathways* 
ANCIENT PATHWAY HORMESIS
Genetic Stability/DNA Repair Heat, Radiation,
Metabolic Control/IGF1, AMPK Diet Restriction, Hibernation
Antioxidant Diet Restriction, Radiation, Heat, Exercise
FOXO/AMPK Energy Disruptors; CR, Exercise, Toxic chemicals
Heat Shock Response Heat, Exercise
Hibernation Cold, Hunger, Ischemia
Immunity Infectious Agents
Regulators
Sirtuins Diet Restriction
Ubiquitin Exercise, Diet Restriction
*See text for explanations and references.
TABLE 2: Mimics of environmental hormesis and disease intervention* 
Disease Hormetic Agents Hormetic Mimics
Diabetes Heat, Exercise Ethanol, GGA
Diet Restriction Biguanides, Resveratrol
Metabolic Inhibitors
AICAR, GW1516
Exercise AICAR, GW1516
Heart Attack Heat, Exercise, Ischemia Ethanol, GGA
Cold, Hunger HIT, Deltorphins
Heart Failure Heat CDRI peptide, GGA
Hemorrhage or Stroke Cold, Hunger, Ischemia HIT, Deltorphins
Cancer Radiation Small Nucleotides, T oligos
UV Damage Products
Thiols, Zinc, Selenium, Oltipraz 
and ferritin agonists
Alzheimer’s Heat Ethanol, GGA
Fatigue Exercise AMPK Agonist AICAR
Infection Heat GGA, CDR1, CpG Islands
Inflammatory Heat, Immune Response GGA, AICAR, Deltorphins**
Diseases:
Rheumatoid arthritis
Osteoarthritis
Lung,Bowel disease
Atherosclerosis
Psoriasis
Alzheimer’s
Post Traumatic Syndrome Deltorphin E**
Hypertension, Atherosclerosis, Diet Restriction AICAR (AMPK-FOXO)
Osteoporosis Heat GGA
*See Hormesis Sections in text for more information and references. The mimetics may induce
common, partial, and unique physiological responses found within the hormetic agent beneficial
dose range.
**Speculation here on the basis of dramatic shock response found in our studies
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diseases, infection vulnerability, atherosclerosis, organ function, acute
ischemic events like heart failure, heart attack, stroke, vessel obstructions
and immune diseases (Table 2). The common denominator for hormet-
ic benefit is the conservation of metabolic pathways that assure survival,
stress resistance, and longevity throughout evolution. Major pathways
include IGF-1, DNA repair, immunology, heat and cold shock proteins,
antioxidants, and metabolic energy switches. The role of chromatin
remodelling, translation regulation, and small RNA induction, contribute
to the coordinated cellular response observed following the stress of
hypoxia (Kenneth and Rocha 2008).
A major toxic response to environmental challenges is oxidative dam-
age, a fundamental and universal denominator that regulates survival,
species longevity, and stress tolerance (Martin et al. 1996). Survival
depends on antioxidant induction pathways, responsive to a wide range
of hormetic agents and their mimetics, that act as natural detoxifying sys-
tems. In diverse species, transcription factors, like the forkhead-box
(FOXO) transcription factor family, activate a broad suite of cellular
genes, including those encoding enzymes involved in DNA repair, oxygen
detoxification and downstream suppression of the life-shortening effects
of insulin/insulin-like growth factor-I receptor. The unique additions and
removal of phosphorylations, acetylations, and ubiquitinations of FOXO
for example, under specific environmental conditions provides specifici-
ty in the regulation of subsets of FOXO target genes (Carter and Brunet
2007). FOXO factors may regulate responses by facilitating different pat-
terns of gene expression at threshold low doses but pro-apoptotic genes
when the intensity of stress stimuli increases beyond a certain threshold
(Carter and Brunet 2007) and thereby explain a basis for some paradox-
ical hormetic responses. Deacetylases, like the sirtuins, activate transcrip-
tion of protective pathways. Diversity of interactions regulating function
may explain diversity of outcomes, including the apparent dose low dose
dependent benefit, versus high dose toxicity typical of hormetic respons-
es to the same agent. The balance in favor of benefit increases when a key
regulator of the desired effect is amplified by the mimetic, like AMPK by
AICAR (Narkar et al. 2008).
The mimetics of hormesis may intervene in acute and chronic and
acute diseases, inflammatory diseases, trauma, pandemics, metabolic dis-
orders, and toxicity of oxidizing and metabolic pollutants. These include;
1. Health benefits from exercise and diet restriction mimetics of
hormetic agents may cross-react since both share involvement of the
FOXO-AMPK and IGF-1 pathways for intervention in energy related
diseases especially diabetes.
2. Antioxidant pathways and triggers of repair pathways represent anti
cancer pathways.
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3. Antiinflammatory mimetics promise treatment strategies for inflam-
matory diseases.
4. Trauma recovery using the deltorphins peptides facilitates tolerance
to shock of heart attack, stroke, hemorrhage, or surgical procedures.
Post-traumatic syndrome may be treatable by Deltorphin D or E.
5. Toxicity of pollutants, known to interfere with PPAR nuclear recep-
tors, like phthalates and organotins may be diminished by regulators
of metabolic homeostasis, AICAR and/or GW1516 or HIT mimetics.
6. Immunity boosters, derived from ancient immune strategies, includ-
ing heat shock inducer, GGA, CpG islands found in bacteria, and
CDR1 sequences found in sharks promise aid in infection tolerance
with Deltorphins.
7. Different doses of the same mimetic agent induce unique physiologi-
cal changes that may explain some non-linear responses or hormetic
effects. The harmful effects can be useful as anticancer therapies
when differences in responses exist between normal and cancer cells.
In general, the mimetics of physical and chemical hormetic agents
can “trick” or trigger a beneficial response by activation of key regulators
of the stress response at the level of transcription, post transcriptional
modifications, and regulation of energy metabolism. The dose responses
are complex and reflect activation of different pathways at different doses
and in different cells; a complexity useful in chemotherapy especially
with agents that act differently in normal versus cancer cells.
SUMMARY
Elegant studies in lower organisms reveal strategies for survival in
plants, bacteria, paramecia, yeast, nematodes, flies, frogs, sharks, rats,
mice, woodchucks, and bears and offer the promise of relief from numer-
ous painful and debilitating diseases for healthy aging. The secrets to sur-
vival lurk in our genes, awaiting access triggers in our conserved pathways
and epigenetic modification potentials. The hormetic mimetics reviewed
here are small nucleotide emergency signals, dipeptides, ethanol, thiols
and metals, and conserved peptide sequences or energy regulators found
throughout evolution that regulate cytokines, cellular immunity, central
and peripheral neuronal pathways, and metabolic pathways. Engineered
mimetics to target key regulators of metabolism imitate the environmen-
tal agents as well. Activation of these ancient cascades accesses prevention
and treatment of disease, infection, aging, and trauma. Different doses of
mimetics may activate different physiological cell, tissue, and organ spe-
cific responses in normal and cancer cells. A complex response, like sur-
vival, therefore, may be non-linear.
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